Shukra Pharmaceuticals Limited (BOM:524632)

Shukra Pharmaceuticals Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	351.23	325.87	745.73	588.34	204.86	111.96
Other Revenue	10.87	-	-	6.59	-0	-
Revenue	362.1	325.87	745.73	594.93	204.86	111.96
Revenue Growth (YoY)	-12.24%	-56.30%	25.35%	190.41%	82.97%	-5.49%
Cost of Revenue	86.72	82.92	445.34	454.25	105.17	27.69
Gross Profit	275.37	242.95	300.39	140.68	99.69	84.27
Selling, General & Admin	84.09	72.02	81.76	53.83	55.4	44.76
Other Operating Expenses	31.58	16.36	2.03	21.88	14.94	21.97
Operating Expenses	148.05	118.43	104.29	94.09	86.96	81.47
Operating Income	127.32	124.52	196.09	46.59	12.73	2.8
Interest Expense	-9.01	-5.21	-2.76	-2.56	-2.81	-0.13
Interest & Investment Income	14.79	14.79	5.59	0.64	0.31	0.47
Other Non Operating Income (Expenses)	-0.74	-0.74	-0.09	-0.25	-0.05	-0.2
EBT Excluding Unusual Items	132.37	133.37	198.83	44.42	10.18	2.93
Other Unusual Items	-	-	-	-	-	-1.95
Pretax Income	132.37	133.37	198.83	44.42	10.18	0.98
Income Tax Expense	12.78	37.61	13.46	0.35	2.67	-0.9
Net Income	119.59	95.75	185.37	44.07	7.51	1.88
Net Income to Common	119.59	95.75	185.37	44.07	7.51	1.88
Net Income Growth	-17.14%	-48.35%	320.68%	486.98%	299.10%	428.31%
Shares Outstanding (Basic)	630	438	438	67	63	63
Shares Outstanding (Diluted)	630	438	438	67	63	63
Shares Change (YoY)	53.87%	-	551.03%	7.38%	-	0.02%
EPS (Basic)	0.19	0.22	0.42	0.66	0.12	0.03
EPS (Diluted)	0.19	0.22	0.42	0.66	0.12	0.03
EPS Growth	-46.15%	-48.35%	-35.38%	446.67%	299.10%	428.20%
Free Cash Flow	-54.33	51.75	-69.57	-13.22	64.39	-12.54
Free Cash Flow Per Share	-0.09	0.12	-0.16	-0.20	1.03	-0.20
Dividend Per Share	0.010	0.010	0.100	0.013	0.013	-
Dividend Growth	-	-90.00%	700.00%	-	-	-
Gross Margin	76.05%	74.55%	40.28%	23.65%	48.66%	75.27%
Operating Margin	35.16%	38.21%	26.30%	7.83%	6.21%	2.50%
Profit Margin	33.03%	29.38%	24.86%	7.41%	3.66%	1.68%
Free Cash Flow Margin	-15.00%	15.88%	-9.33%	-2.22%	31.43%	-11.20%
EBITDA	159.7	154.57	216.59	64.96	29.35	17.53
EBITDA Margin	44.10%	47.43%	29.04%	10.92%	14.33%	15.66%
D&A For EBITDA	32.38	30.05	20.5	18.38	16.62	14.74
EBIT	127.32	124.52	196.09	46.59	12.73	2.8
EBIT Margin	35.16%	38.21%	26.30%	7.83%	6.21%	2.50%
Effective Tax Rate	9.65%	28.20%	6.77%	0.79%	26.26%	-
Revenue as Reported	404.17	367.94	773.88	600.3	205.67	115.52
Advertising Expenses	-	3.63	21.21	0.1	0.09	0.41

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.